Skip to main content

Effects of Tranexamic Acid on the Coagulation and Fibrinolytic Systems in Pregnancy Complicated by Placental Bleeding

  • Conference paper
New Toxicology for Old

Part of the book series: Archives of Toxicology ((TOXICOLOGY,volume 5))

Abstract

Treatment with the fibrinolytic inhibitor tranexamic acid was investigated in 12 women with vaginal bleeding in the second half of pregnancy. The aim of the therapy was to accelerate haemostasis in the uteroplacental circulation and to prevent further bleeding at the placental site. Tranexamic acid 1 g 8-hourly was given for 7 days. Serial investigations of coagulation and fibrinolysis were carried out. Plasma fibrinolytic activity, plasminogen, antiplasmin and platelet count significantly decreased during treatment, while antithrombin III and factor VIII related antigen showed a significant increase. Plasma tranexamic acid levels ranged from 5 mg/1 to 17 mg/1. Two patients on treatment at the time of delivery had plasma tranexamic acid levels of 9 mg/1 and 12 mg/1 detected in the umbilical cord venous blood. No adverse effects were detected in any of the mothers and all 12 were delivered of live born infants. Tranexamic acid may have a therapeutic role in accelerating haemostasis in the uteroplacental circulation and thereby reducing the adverse effects of bleeding at the placental site.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andersson L, Nilsson IM, Nilehn J-E, Hedner U, Grandstand B, Melander B (1965) Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-amionmethyl cyclohexane carboxylic acid. Scand J Haematol 2: 230–247

    Article  PubMed  CAS  Google Scholar 

  • Biggs R, Eveling J, Richards G (1955) The assay of antihaemophilic globulin activity. Br J Haematol 1: 20

    Article  PubMed  CAS  Google Scholar 

  • Bonnar J (1978) Haemostatic function and coagulopathy during pregnancy. In: Wynn RM (ed) Obstetrics and gynecology annual, vol 7. Appleton-Century-Crofts, New York, pp 195–217

    Google Scholar 

  • Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17: 237

    Article  PubMed  CAS  Google Scholar 

  • Collen D, Tytgat G, Claeys H, Verstraete M, Wallen P (1972a) Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. J Clin Invest 51: 1310–1318

    Article  PubMed  CAS  Google Scholar 

  • Collen D, Tytgat GN, Claeys H, Piessens R (1972b) Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. Br J Haematol 22: 681–700

    Article  PubMed  CAS  Google Scholar 

  • Cultrera G, Lampugnani P (1973) Fibrinogen-Turnover nach Verabreichung von Hirnphospholipiden in Kombination mit einem Antifibrinolytikum ( AMCHA ). Arzneim Forsch 23: 445–447

    CAS  Google Scholar 

  • Hoylaerts M, Lijnen HR, Collen D (1981) Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 673: 75–85

    PubMed  CAS  Google Scholar 

  • Kluft C, Brakman P, Veldhuyzen-Stolk EC (1976) Screening of fibrinolytic activity in plasma euglobulin fractions on the fibrin plate. In: Davidson JF, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis, vol 2. Ravens Press, New York

    Google Scholar 

  • Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45

    Article  PubMed  CAS  Google Scholar 

  • Pilbrant A, Schannong M, Vessman J (1981) Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 20: 65–72

    Article  PubMed  CAS  Google Scholar 

  • Poller L, Thomson JM, Sear CHJ, Thomas W (1971) Identification of a congenital defect of factor VII in a colony of beagle dogs: the chemical use of the plasma J Clin Pathol 24: 626

    Article  PubMed  CAS  Google Scholar 

  • Sheppard BL, Bonnar J (1974) The ultrastructure of the arterial supply of the human placenta in early and late pregnancy. J Obstet Gynaecol Br Commonw 81: 497–511

    Article  PubMed  CAS  Google Scholar 

  • Sheppard BL, Bonnar J (1978) Fibrinolysis in decidual spiral arteries in late pregnancy. Thromb Haemostasis 39: 751–757

    CAS  Google Scholar 

  • Spragg J (1978) Specific functional and immunologic assay of plasma plasminogen in hereditary angioedema treated with tranexamic acid, and in normal subjects. J Immunol 120: 592–596

    PubMed  CAS  Google Scholar 

  • Thomson J (1980) Blood coagulation and haemostasis: a practical guide. Churchill Livingstone, Edinburgh London New York

    Google Scholar 

  • Todd AS (1959) Histological localization of fibrinolysis activator. J Pathol Bacteriol 78: 281–283

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag

About this paper

Cite this paper

Walzman, M., Bonnar, J. (1982). Effects of Tranexamic Acid on the Coagulation and Fibrinolytic Systems in Pregnancy Complicated by Placental Bleeding. In: Chambers, C.M., Chambers, P.L. (eds) New Toxicology for Old. Archives of Toxicology, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68511-8_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68511-8_39

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-11406-2

  • Online ISBN: 978-3-642-68511-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics